Journal of Neural Transmission

Article	Citations
Recent advances in our understanding of the organization of dorsal horn neuron populations and their contribution to cutaneous mechanical allodynia	73
Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Ried	46
Effects of safinamide on pain in Parkinson’s disease with motor fluctuations: an exploratory study	39
Recent update on the heterogeneity of the Alzheimer’s disease spectrum	38
Dystonia updates: definition, nomenclature, clinical classification, and etiology	38
Impact of the COVID-19 lockdown on screen media use in patients referred for ADHD to child and adolescent psychiatry: an introduction to problematic use of the internet in ADHD and results of a survey	37
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity	36
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease	35
Contemporary functional neuroanatomy and pathophysiology of dystonia	34
Neuropathological assessment of the Alzheimer spectrum	34
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials	32
Do not keep it simple: recent advances in the generation of complex organoids	30
Neuronal intranuclear inclusion disease: recognition and update	28
Emerging and converging molecular mechanisms in dystonia	28
Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variation	25
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration	25
ADHD at the workplace: ADHD symptoms, diagnostic status, and work-related functioning	23
Iron and inflammation: in vivo and post-mortem studies in Parkinson’s disease	23
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice	23
A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease	23
Genetic and environmental factors of schizophrenia and autism spectrum disorder: insights from twin studies	22
Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis	22
GBA-associated PD: chances and obstacles for targeted treatment strategies	22
COVID-19 outcomes of 10,881 patients: retrospective study of neurological symptoms and associated manifestations (Philippine CORONA Study)	21
A brief history of brain iron accumulation in Parkinson disease and related disorders	21

Demographic and clinical determinants of neck pain in idiopathic cervical dystonia	21
Hypothyroidism after radiation exposure: brief narrative review	21
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t	20
Mental health dished up—the use of iPSC models in neuropsychiatric research	20
The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson’s disease	20
Viruses, parkinsonism and Parkinson’s disease: the past, present and future	20
Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan	19
Glucocerebrosidase mutations and Parkinson disease	19
Chorea in children: etiology, diagnostic approach and management	19
Safinamide improves executive functions in fluctuating Parkinson’s disease patients: an exploratory study	19
Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson’s disease: mutational spectrum and clinical features	19
Metacognition in adult ADHD: subjective and objective perspectives on self-awareness of cognitive functioning	19
Improvement of brain functional connectivity in autism spectrum disorder: an exploratory study on the potential use of virtual reality	19
Language in autism: domains, profiles and co-occurring conditions	18
Morphological basis of Parkinson disease-associated cognitive impairment: an update	18
Feigning ADHD and stimulant misuse among Dutch university students	18
Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson’s disease	18
Neurorehabilitation in dystonia: a holistic perspective	18
Neuropsychological functioning of individuals at clinical evaluation of adult ADHD	18
Genes and hormones of the hypothalamic–pituitary–adrenal axis in post-traumatic stress disorder. What is their role in symptom expression and treatment response?	18
Neurodegenerative proteinopathies associated with neuroinfections	18
Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements	18
Autoimmune encephalitis with psychiatric features in adults: historical evolution and prospective challenge	17
SIRT1 and SIRT2 modulators reduce LPS-induced inflammation in HAPI microglial cells and protect SH-SY5Y neuronal cells in vitro	17
Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis	17
From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview	17
Parkinson and depression: review and outlook	17
Cognitive characterization of adult attention deficit hyperactivity disorder by domains: a systematic review	17
Cerebral white matter changes in deficit and non-deficit subtypes of schizophrenia	17
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease	17
Isolated dystonia: clinical and genetic updates	16
Recent trends in mental illness and omega-3 fatty acids	16
The pathobiological basis of depression in Parkinson disease: challenges and outlooks	15
Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis	15
The MPTP-lesioned marmoset model of Parkinson’s disease: proposed efficacy thresholds that may potentially predict successful clinical trial results	15
The cerebral blood flow deficits in Parkinson’s disease with mild cognitive impairment using arterial spin labeling MRI	14
Emergent creativity in frontotemporal dementia	14
Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses	14
Protein clearance strategies for disease intervention	14
Prevalence and sort of pharmacokinetic drug–drug interactions in hospitalized psychiatric patients	14
Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease	14
Evaluation for Parkinsonian Bradykinesia by deep learning modeling of kinematic parameters	14
Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort	13
Botulinum toxin therapy of dystonia	13
Beyond tics: movement disorders in patients with Tourette syndrome	13
The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease	13
Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network	13
Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases	13
Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids	13
Neuropathological findings in multiple system atrophy with cognitive impairment	13

Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias	13
ADHD and offending	12
The heterogeneity of Parkinson’s disease	12
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort	12
Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors	12
Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach	12
Combined dystonias: clinical and genetic updates	12
Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders	11
Comparison of the rate of dedifferentiation with increasing passages among cell sources for an in vitro model of the blood–brain barrier	11
Effects of head trauma and sport participation in young-onset Parkinson’s disease	11
Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS)	11
Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients	11
Current experimental disease-modifying therapeutics for multiple system atrophy	11
Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia	11
Hemispheric asymmetries in mental disorders: evidence from rodent studies	11
Complex dystonias: an update on diagnosis and care	11
Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress	11
The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models	11
Resident CD34-positive cells contribute to peri-endothelial cells and vascular morphogenesis in salivary gland after irradiation	11
Interleukin-6 secretion upon acute psychosocial stress as a potential predictor of psychotherapy outcome in posttraumatic stress disorder	10
Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update	10
Normal pressure hydrocephalus and CSF tap test response: the gait phenotype matters	10
Transcranial random noise stimulation over the primary motor cortex in PD-MCI patients: a crossover, randomized, sham-controlled study	10
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes	10
Anxiety, depression and psychosocial needs are the most frequent concerns reported by patients: preliminary results of a comparative explorative analysis of two hospital-based palliative care teams in	10
Synaptic plasticity mechanisms behind TMS efficacy: insights from its application to animal models	10
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor	10
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey	10
Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017	10
Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson’s disease in the MARK-PD study	10
Internet-based cognitive behavioral therapy in children and adolescents with obsessive compulsive disorder: a feasibility study	10
Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors	10
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease	9
α7 nicotinic receptors contributes to glutamatergic activity in the hippocampus of patients with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS)	9
Associations of age, sex, sexual abuse, and genotype with monoamine oxidase a gene methylation	9
Gaze behavior is associated with the cortisol response to acute psychosocial stress in the virtual TSST	9
Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors	9
Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue	9
Autism Spectrum Disorder and auditory sensory alterations: a systematic review on the integrity of cognitive and neuronal functions related to auditory processing	9
Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson’s disease	9
Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease	9
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes	9
Stress and pain: modality-specific opioid mediation of stress-induced analgesia	9
Non-credible symptom report in the clinical evaluation of adult ADHD: development and initial validation of a new validity index embedded in the Conners’ adult ADHD rating scales	9
Botulinum toxin therapy: past, present and future developments	9
Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson’s disease	9
The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19	9
Voxel-based lesion symptom mapping analysis for dysphagia in stroke patients with isolated cerebellar lesions	8
Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer’s disease	8
Implications of dopaminergic medication withdrawal in Parkinson’s disease	8
Life style and Parkinson’s disease	8
Is the vertex a good control stimulation site? Theta burst stimulation in healthy controls	8
NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity	8
Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly	8
Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study	8
Suboptimal response to STN-DBS in Parkinson’s disease can be identified via reaction times in a motor cognitive paradigm	8
Associations between age and cortisol awakening response in patients with borderline personality disorder	8
Long-term effects of chronic stress models in adult mice	8
A historical review of multiple system atrophy with a critical appraisal of cellular and animal models	8
Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits	8
Association of early and later depressive symptoms with functional outcome after ischemic stroke	8
Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmoset	8
Autophagy in trimethyltin-induced neurodegeneration	8
C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy	8
Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset	8
Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients	8
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment	8
Tau proteins in blood as biomarkers of Alzheimer’s disease and other proteinopathies	8
Dystonia and leveraging oral pharmacotherapy	7
The impact of maternal care and blood glucose availability on the cortisol stress response in fasted women	7
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles	7
Impact of the COVID-19 pandemic on mental health and family situation of clinically referred children and adolescents in Switzerland: results of a survey among mental health care professionals after 1	7
X-linked dystonia Parkinsonism: crossing a new threshold	7
The enigma of vascular depression in old age: a critical update	7
Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis	7
Essential tremor plus rest tremor: current concepts and controversies	7
Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study	7
Evidence supporting the role of telomerase, MMP-9, and SIRT1 in attention-deficit/hyperactivity disorder (ADHD)	7
The mGlu2/3 antagonist LY-341,495 reverses the anti-dyskinetic and anti-psychotic effects of the mGlu2 activators LY-487,379 and LY-354,740 in the MPTP-lesioned marmoset	7
Genome-wide methylation association with current suicidal ideation in schizophrenia	7

Depression in dementia with Lewy bodies: a critical update	7
Assessment and treatment of substance use in adults with ADHD: a psychological approach	7
Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down?	7
Disease modification in Parkinsonism: obstacles and ways forward	7
Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study	7
Small intestinal bacterial overgrowth in Alzheimer’s disease	7
Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?	7
Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients	7
Oscillatory activity in the BNST/ALIC and the frontal cortex in OCD: acute effects of DBS	7
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson’s disease	7
The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder	7
Genetic updates on paroxysmal dyskinesias	6
Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels	6
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study	6
Patients with higher vitamin D levels show stronger improvement of self-reported depressive symptoms in psychogeriatric day-care setting	6
Betrayed by the nervous system: a comparison group study to investigate the ‘unsafe world’ model of selective mutism	6
GenIDA: an international participatory database to gain knowledge on health issues related to genetic forms of neurodevelopmental disorders	6
Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations	6
Bioinformatics approach reveals the critical role of the NOD-like receptor signaling pathway in COVID-19-associated multiple sclerosis syndrome	6
Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder	6
DNA hypomethylation of the Krüppel-like factor 11 (KLF11) gene promoter: a putative biomarker of depression comorbidity in panic disorder and of non-anxious depression?	6
Dual task gait deteriorates gait performance in cervical dystonia patients: a pilot study	6
Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry	6
Tryptophan modulation in individuals with attention deficit hyperactivity disorder: a systematic review	6
The importance of genetic testing for dystonia patients and translational research	6
Brain volumes and dual-task performance correlates among individuals with cognitive impairment: a retrospective analysis	6
Public perceptions of adult ADHD: Indications of stigma?	6
A sudden and severe depressive episode after a left cingulate gyrus stroke: a case report of post-stroke depression and review of literature	6
Genetic and epigenetic analyses of panic disorder in the post-GWAS era	6
Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression	6
Serum NfL and CHI3L1 for ALS and parkinsonian disorders in the process of diagnosis	6
Endothelial nitric oxide synthase (NOS3) rs2070744 polymorphism and risk for multiple sclerosis	6
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone	6
Efficacy of adjunctive d-Cycloserine for the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials	6
New modalities and directions for dystonia care	6
Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient care	6
The use of wearables for the diagnosis and treatment of Parkinson’s disease	6
Blood neurofilament light chain in Parkinson’s disease	6
Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt–Jakob disease in clinical practice	6
Neurocognitive profile of patients with X-linked dystonia-parkinsonism	5
Abnormal cerebellum connectivity patterns related to motor subtypes of Parkinson’s disease	5
Effects of intrathecal baclofen therapy in subjects with disorders of consciousness: a reappraisal	5
Caregiver burden in patients with behavioural variant frontotemporal dementia and non-fluent variant and semantic variant primary progressive aphasia	5
Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug	5
Role of mechanosensitive ion channels in the sensation of pain	5
Effects of systemic glycine on accumbal glycine and dopamine levels and ethanol intake in male Wistar rats	5
Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity	5
Influence of stress on physiological synchrony in a stressful versus non-stressful group setting	5
Covariation of psychobiological stress regulation with valence and quantity of social interactions in everyday life: disentangling intra- and interindividual sources of variation	5
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review	5
COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study	5
Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters	5
Cognition, motor symptoms, and glycolipid metabolism in Parkinson’s disease with depressive symptoms	5
Hyposmia may predict development of freezing of gait in Parkinson’s disease	5
Sex differences in schizophrenia: a longitudinal methylome analysis	5
Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage	5
The role of stress coping strategies for life impairments in ADHD	5
The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin	5
Arching deep brain stimulation in dystonia types	5
Association between heart rate variability and striatal dopamine depletion in Parkinson’s disease	5
Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy	5
Insights into Lewy body disease from rare neurometabolic disorders	5
9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes	5
Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations	5
Issues for patchy tissues: defining roles for gut-associated lymphoid tissue in neurodevelopment and disease	5
Remdesivir shifts circadian rhythmicity to eveningness; similar to the most prevalent chronotype in ADHD	5
Iron and copper ions accelerate and modify dopamine oxidation to eumelanin: implications for neuromelanin genesis	5
REM sleep absence in patients referred to polysomnography for REM sleep behavior disorder	5
Neurophysiological investigation of auditory intensity dependence in patients with Parkinson’s disease	4
Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson’s disease	4
Reduced vagal activity in borderline personality disorder is unaffected by intranasal oxytocin administration, but predicted by the interaction between childhood trauma and attachment insecurity	4
Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuries	4
Differential spatial distribution of white matter lesions in Parkinson’s and Alzheimer’s diseases and cognitive sequelae	4
Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?	4
Changes in the TMS-evoked potential N100 in the dorsolateral prefrontal cortex as a function of depression severity in adolescents	4
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder	4
Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study	4
Three-way interaction effects of early life stress, positive parenting and FKBP5 in the development of depressive symptoms in a general population	4
The language profile in multiple system atrophy: an exploratory study	4
Fluid markers of synapse degeneration in synucleinopathies	4
The immediate effect of stroboscopic visual training on information-processing time in people with multiple sclerosis: an exploratory study	4
Ultrastructural characterization of peripheral denervation in a mouse model of Type III spinal muscular atrophy	4
Proteinopathies associated to repeat expansion disorders	4
Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease	4
Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism	4
Diagnostic value of micrographia in Parkinson’s disease: a study with [123I]FP-CIT SPECT	4
The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors	4
Polymorphisms of COMT and CREB1 are associated with treatment-resistant depression in a Chinese Han population	4
Contemporary clinical neurophysiology applications in dystonia	4
Why do anti-inflammatory signals of bone marrow-derived stromal cells improve neurodegenerative conditions where anti-inflammatory drugs fail?	4
Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study	4
Plasma concentrations of anti-inflammatory cytokine TGF-β are associated with hippocampal structure related to explicit memory performance in older adults	4
Genetic testing for Parkinson’s disease in clinical practice	4
Gastrointestinal mucosal biopsies in Parkinson’s disease: beyond alpha-synuclein detection	4
Tractography patterns of pedunculopontine nucleus deep brain stimulation	4